《亚洲经济》日本12月国内企业商品价年升加快至0.9%创八个月高 符预期
日本央行数据显示,经季节调整後,日本去年12月国内企业商品物价指数(CGPI)按月升幅续略放缓至0.1%,符合市场预期;按年升幅加快至0.9%(前值半年来首升0.1%),为八个月来最大升幅,符合市场预期。
期内,以合同货币基准计算(下同)出口价格环比持平(前值转降0.3%);按年降幅收窄至2.2%(前值维持降3.4%至少逾一年最伤),但已连跌13个月。进口价格按月弹0.6%(前值略下修续降0.4%),结束连降三个月;按年跌幅再度收窄至4.6%(前值略下修降幅扩至8.6%至少为逾一年最伤),但已连跌12个月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.